STAT

OCTOBER 25, 2023

Alison Buttenheim was floored by a sign she saw in her doctor’s office when she went to get the first jab of the two-dose shingles vaccine to protect her against painful flare-ups of varicella zoster. “Medicare patients cannot receive Tdap or zoster vaccines here. They need to obtain [them] at their pharmacy. If they receive it here, they need to pay out of pocket,” the notice read.

Vaccines 363

Vaccines Immunity Immunization 363

PharmaVoice

OCTOBER 25, 2023

“They have the money,” and they’re using it to influence drug development, according to the executive director of the IQVIA Institute for Human Data Science.

Drug Development 322

Drug Development 322

STAT

OCTOBER 25, 2023

PHILADELPHIA — Cesar de la Fuente believes the next breakthrough antibiotic might come from animals that have been dead for thousands of years. Since 2021, his lab here at the University of Pennsylvania has built algorithms to trawl genetic databases for protein fragments, called peptides, with microbe-squashing properties. They started with human DNA.

354

354

PharmaVoice

OCTOBER 25, 2023

The Cigna-owned pharmacy benefit manager colluded with rival Prime Therapeutics to overcharge pharmacies, according to a lawsuit filed last week.

Independent Pharmacies 130

Independent Pharmacies 130

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

OCTOBER 25, 2023

An experimental treatment for Alzheimer’s disease that removes a toxic protein called tau from brain cells showed “favorable trends” across several measures of cognition and function in a small study — results that offer some hope for an emerging drug class that has failed to deliver benefits in the past. The drug, called BIIB080, is being developed by Biogen.

Drug Development 341

Drug Development 341

Pharma Times

OCTOBER 25, 2023

The APPG has called for urgent improvements in rural and ethnically diverse-areas - News - PharmaTimes

149

149

Express Pharma

OCTOBER 25, 2023

Dr Reddy’s Laboratories announced the launch of its first direct-to-consumer (D2C) e-commerce website ‘Celevida Wellness’ for diabetes patients by its wholly-owned subsidiary, Svaas Wellness. A company statement informed, “The website will host the Celevida range of products as well as other third-party brands to offer a product portfolio that takes care of a diabetic patient’s daily nutritional requirement and at the same time fits into the complete occasion framework of the day i.e., breakfast

Diabetes 116

Diabetes 116

STAT

OCTOBER 25, 2023

Oncologists were more likely to provide low-value cancer care after receiving money from pharmaceutical companies, and the findings raise questions about the extent to which industry influence may have led to patient harm, according to a new study. The study looked at two scenarios: medications that were not recommended for treating a particular cancer, such as denosumab, which is administered for prostate cancer, and GCSF medications that are used to stimulate the bone marrow to make blood cell

Chemotherapy 326

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 326

Pharmacy Joe

OCTOBER 25, 2023

In this episode, I’ll discuss what happened to the “ISMP’s Do Not Crush List.” Episode 864: Why Did ISMP Remove the Do Not Crush List from Their Website? Subscribe on iTunes , Android , or Stitcher If you navigate to the page on the website for the Institute for Safe Medication Practices that once hosted the document titled “Oral Dosage Forms That Should Not Be Crushed” you will instead find a notice that the list has been removed from the ISMP website.

Dosage 111

Dosage Inpatient Packaging Documentation 111

STAT

OCTOBER 25, 2023

A version of the Alzheimer’s disease drug Leqembi that can be given with a simpler, under-the-skin injection is equally effective as the currently approved intravenous infusion, according to study results presented Wednesday by its maker, Eisai. But hopes that the subcutaneous injection would also cause lower rates of brain swelling and bleeding — the drug’s most worrisome side effects — were not borne out in the study.

311

311

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Drug Patent Watch

OCTOBER 25, 2023

DrugPatentWatch has published a list of research papers citing DrugPatentWatch at [link] DrugPatentWatch.com is your key to unlocking the world of pharmaceutical research. These primary literature citations can benefit researchers,… The post List of research papers citing DrugPatentWatch appeared first on DrugPatentWatch - Make Better Decisions.

111

111

STAT

OCTOBER 25, 2023

Visit the website of cardiologist Ruey Hu, and you can scroll through his prolific scientific articles neatly arranged into 11 sections by study type, peruse a folder of medical education resources, and browse links to a couple of hand-coded tools. More curiously, there’s also a tab labeled, “Composing.” There live three sheets of music for works titled “Gauntlet,” “Topsody,” and “Renewal.

Labelling 307

Labelling 307

Pharma Times

OCTOBER 25, 2023

The company will launch a clinical investigation of EA-2351 for geographic atrophy - News - PharmaTimes

138

138

STAT

OCTOBER 25, 2023

European drug regulators are updating regulations to stem drug shortages. Are there lessons for Americans? Drug shortages are not solely an American problem. Last winter, European supplies of common antibiotics were critically low, especially for children, due to the surge of respiratory infections that followed two years of laying low to avoid Covid-19.

Communication 288

Communication Drug Pricing 288

Express Pharma

OCTOBER 25, 2023

Researchers from Indian Institute of Technology Mandi , the Institute for Stem Cell Science and Regenerative Medicine in Bengaluru, have discovered the biochemical processes that enable the eggs of the Dengue-causing mosquito to survive harsh conditions and rejuvenate when favourable conditions return. This research marks a significant stride in our battle against mosquito-borne diseases, offering hope for more effective vector control measures.

105

105

STAT

OCTOBER 25, 2023

It’s a disease of children living in extreme poverty. Its cause is uncertain. So is the number of children it affects. But soon, the devastating condition known as noma may be a bit less neglected.

287

287

Med Ed 101

OCTOBER 25, 2023

The CDC has approved RSV vaccines for patients over the age of 60 and those who are pregnant. We provide an RSV vaccine comparison table below to help you recognize the differences between these vaccines and who may benefit from vaccination. RSV Vaccine Comparison Table: GSK’s Arevxy study, AResVi-006, in comparison to Psizer’s Abrysvo study, […] The post RSV Vaccine Comparison Table appeared first on Med Ed 101.

Vaccines 96

Vaccines 96

STAT

OCTOBER 25, 2023

I was sitting in my car around 4 p.m. on a Friday, waiting in the parking lot to be called in for my pre-delivery Covid test. I was equally exhausted from the physical demands of my second pregnancy and the emotional labor of typing up my loose ends at work with hundreds of patients. That’s when I received an email from an administrator at the hospital where I worked.

Hospitals 283

Hospitals 283

European Pharmaceutical Review

OCTOBER 25, 2023

SGS ISL forms part of an important biotechnology and pharmaceutical hub. The laboratory not only provides crucial support to manufacturing activities in Ireland but also leverages its rich history to contribute to global pharmaceutical operations and supply chains around the world. The facility underwent a successful inspection by the HPRA and transitioned onto the SGS network’s global LIMS and QMS platforms.

95

95

STAT

OCTOBER 25, 2023

Novartis has gone to court to gain access to Takeda Pharmaceutical documents over concerns that a former employee took trade secrets with him to his new job at the rival drugmaker. In a complaint filed in Massachusetts Superior Court, Novartis claimed that Khaled Shams Eldin transferred approximately 10,000 company files to his personal e-mail before leaving his job last May in Cairo, where he most recently worked in technical operations handling site divestments and relationships with suppliers

Documentation 241

Documentation 241

Express Pharma

OCTOBER 25, 2023

With influenza season well underway, vaccination campaigns are in full force in the northern hemisphere. In the UK, the National Health Service (NHS) has delivered its fastest ever rollout of the influenza vaccine, with a record 10 million people already vaccinated with quadrivalent (four-strain) vaccines such as AstraZeneca’s Fluenz Tetra and Viatris’ Influvac Tetra.

Vaccines 96

Vaccines 96

STAT

OCTOBER 25, 2023

A drug-coated balloon made by Boston Scientific reduced the risk of heart attack in patients with complications from stents, researchers reported on Wednesday. Boston Scientific hopes to use this data to win approval from the Food and Drug Administration. The company has not yet published its full slate of data in a journal. Outside experts told STAT they needed more data before assessing the device’s full potential.

225

225

European Pharmaceutical Review

OCTOBER 25, 2023

Three key medicine regulatory bodies from the UK, US and Canada have collaborated to publish five guiding principles for machine learning-enabled medical devices MLMDs. The document by the Medicines and Healthcare products Regulatory Agency (MHRA), US Food and Drug Administration (FDA) and Health Canada, contains key guidance on predetermined change control plans (PCCPs) for MLMDs.

Documentation 92

Documentation 92

STAT

OCTOBER 25, 2023

As one of the largest and oldest medical device companies in the world, Medtronic has a foot in almost every clinical area. The device maker with a market valuation of nearly $100 billion sells pacemakers, spinal cord stimulators, stents, monitors. Name a device, and they probably make it. The behemoth is ubiquitous in health care, but its size can make innovation sluggish.

Diabetes 201

Diabetes 201

European Pharmaceutical Review

OCTOBER 25, 2023

CPHI Barcelona has announced the winners of 2023 CPHI Pharma Awards. These recognise outstanding achievements and contributions from the global pharmaceutical industry and supply chain across 12 broad categories. Winners of the 2023 CPHI Pharma Award – highlights For spearheading Procos’ growth, the company’s CEO Enrico Zodio, won CEO of the Year award for enabling the contract development and manufacturing organisation (CDMO) to achieve a current turnover in excess of €200 million.

Packaging 92

Packaging 92

STAT

OCTOBER 25, 2023

Good morning, everyone, and how are you today? We are doing just fine, thank you. After all, the birds are still chirping and a cool breeze is wafting by the placid Pharmalot campus. Moreover, this marks the middle of the week, which means we have managed to survive this far. And this calls for celebration, yes? So please join us as we hoist another cup of delicious stimulation.

Drug Pricing 184

Drug Pricing 184

Express Pharma

OCTOBER 25, 2023

MSD (known as Merck in US and Canada) announced that the Drug Controller General of India (DCGI) has approved KEYTRUDA (pembrolizumab), MSD’s anti-PD-1 therapy, for the treatment of triple-negative breast cancer and renal cell carcinoma in adults. KEYTRUDA has been approved for high-risk early-stage and metastatic triple-negative breast cancer for select patients who are at a high risk of recurrence.

Immunity 94

Immunity Immunization Chemotherapy 94

STAT

OCTOBER 25, 2023

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello, everyone. Damian here with a look at biotech’s latest nadir, the virtues of Neanderthal DNA, and the sudden success of a decades-old idea in oncology.

Drug Pricing 155

Drug Pricing Drug Development 155

Pharmaceutical Technology

OCTOBER 25, 2023

The AD and PD drug aims to reduce the level of neurotoxic proteins, thereby improving information flow across the axonal transport

98

98

World Pharma News

OCTOBER 25, 2023

Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, announced that 20 company abstracts will be presented at the European Society for Gene and Cell Therapy (ESGCT) 30th Congress, which is being held in Brussels, Belgium, from October 24 to 27, 2023.

81

81

pharmaphorum

OCTOBER 25, 2023

Melissa Little is CEO of the Novo Nordisk Foundation Centre for Stem Cell Medicine, or reNEW

114

114

Outsourcing Pharma

OCTOBER 25, 2023

Advanced tech company, PhaseV, has raised $15 million in funding that it says it will use to âpush the boundaries of machine learning for clinical trial optimizationâ.

80

80

pharmaphorum

OCTOBER 25, 2023

AI in wound: Delivering advanced care through a national wound registry Mike.

121

121

The Pharmacist

OCTOBER 25, 2023

The Pharmacists’ Defence Association (PDA) has reiterated calls for the regulation of non-clinical managers as the government sets out the scope of its inquiry into the Lucy Letby case. While the PDA welcomed the government’s upcoming inquiry into the murders and attempted murders committed by former neonatal nurse Letby, director Paul Day said that it […] The post Letby inquiry ‘should not delay’ regulation of non-clinical managers appeared first on The Pharmacist.

Clinic Management 75

Clinic Management 75

BioPharma Dive

OCTOBER 25, 2023

An under-the-skin injection of Leqembi performed about the same as the already marketed intravenous form, according to trial results presented Wednesday. A new approval application is expected by the end of March.

65

65